Functional p53 is required for rapid restoration of daunorubicin-induced lesions of the spleen (Q34810055)

4 August 2017

title

Functional p53 is required for rapid restoration of daunorubicin-induced lesions of the spleen (English)

1 reference

4 August 2017

3

Bjørn Tore Gjertsen

1 reference

4 August 2017

4

Stein Ove Døskeland

1 reference

4 August 2017

Lars Herfindal

1

1 reference

4 August 2017

Lene Myhren

series ordinal

2

1 reference

4 August 2017

Gro Gausdal

series ordinal

5

1 reference

4 August 2017

language of work or name

English

0 references

publication date

11 July 2013

1 reference

4 August 2017

1 reference

4 August 2017

volume

13

1 reference

4 August 2017

page(s)

341

1 reference

Assessing the radiation response of lung cancer with different gene mutations using genetically engineered mice.

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

Exploiting synthetic lethal interactions between DNA damage signaling, checkpoint control, and p53 for targeted cancer therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

Allele-specific p53 mutant reactivation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

Inhibitory role of E2F-1 in the regulation of tumor suppressor p53 during DNA damage response

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

Targeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myeloma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

Caspase-dependent, geldanamycin-enhanced cleavage of co-chaperone p23 in leukemic apoptosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

Tumor spectrum analysis in p53-mutant mice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

Splenic lipofuscinosis in mice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3710475

Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-341

Predicting response to cancer chemotherapy: the role of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-341

Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-13-341

p63 and p73 are required for p53-dependent apoptosis in response to DNA damage

21 January 2018

2 references

https://api.crossref.org/works/10.1186%2F1471-2407-13-341

21 January 2018

12 December 2020

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

1 reference

12 December 2020

Migration of stem cells and progenitors between marrow and spleen following thiamphenicol treatment of mice

1 reference

12 December 2020

Increasing therapeutic effect and reducing toxicity of doxorubicin by N-acyl dehydroalanines

1 reference

12 December 2020

Changes of lipofuscin-like pigments in erythrocytes and spleen after whole-body gamma irradiation of rats

1 reference

12 December 2020

p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cells

1 reference

12 December 2020

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

12 December 2020

p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-13-341

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference